Profile
| Metric | Value |
|---|---|
| Full Name | Elevance Health, Inc. |
| Ticker | NYSE: ELV |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Healthcare Plans |
| Country | United States |
| IPO | |
| Indexes | |
| Website | elevancehealth.com |
| Employees | 104,200 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $374.87 | |
| Price, 1D Change | -1.85% | |
| Market Cap | $83B | |
| TTM Dividend Yield | 1.82% | |
| PE Ratio | 15.33 | |
| Beta | 0.18 | |
| Revenue | $177B | |
| Revenue, 1Y Change | +3.19% | |
| EPS | $25.68 | |
| EPS, 1Y Change | +1.81% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $1.71 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 2:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | ANTM | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $25.68 | |
| EPS Estimate | $29.98 | |
| EPS Est. Change | +16.75% | |
| Revenue | $176.81B | |
| Revenue Estimate | $197.63B | |
| Revenue Est. Change | +11.78% | |
| Current Price | $374.87 | |
| Price Target | - | $400.00 |
| Price Tgt. Change | - | +6.70% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $33.09 | $25.22 | -23.79% | |
| $32.97 | $25.68 | -22.11% | |
| $29.98 | N/A | +16.75% | |
| $26.88 | N/A | +4.70% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $170.20B | $171.34B | +0.67% | |
| $174.96B | $176.81B | +1.06% | |
| $197.63B | N/A | +11.78% | |
| $203.77B | N/A | +15.25% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -2.70% | |
| Price, 3Y | -22.39% | |
| Market Cap, 1Y | -4.94% | |
| Market Cap, 3Y | -27.51% | |
| Revenue, 1Y | +3.19% | |
| Revenue, 3Y | +27.53% | |
| EPS, 1Y | +1.81% | |
| EPS, 3Y | +3.82% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $374.87 | |
| SMA 200 | $350.58 | |
| SMA 200 vs Price | -6.48% | |
| SMA 50 | $342.57 | |
| SMA 50 vs Price | -8.62% | |
| Beta | 0.18 | |
| ATR | $9.23 | |
| 14-Day RSI | 63.21 | |
| 10-Day Volatility | 27.06% | |
| 1-Year Volatility | 36.42% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $1.71 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 1.74% | |
| Total Dividend | $6.52 | |
| Dividends Paid | $1.51B | |
| Payout Ratio | 25.26% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $176.81B | |
| EPS | $25.68 | |
| Gross Profit | $0.00 | |
| Gross Margin | 0.00% | |
| Operating Profit | $8.89B | |
| Operating Margin | 5.03% | |
| Net Income | $5.97B | |
| Net Margin | 3.38% | |
| EBITDA | $9.30B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.76 | |
| Current Ratio | 1.45 | |
| - | ||
| - | ||
| F-Score | 6 | |
| Altman Z-Score | 2.99 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 15.33 | |
| PS Ratio | 0.43 | |
| PB Ratio | 1.90 | |
| EV/EBITDA | 12.35 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $41.32B | |
| Cash & Equivalents | $8.29B | |
| Total Assets | $116.89B | |
| Current Assets | $58.94B | |
| Total Liabilities | $75.46B | |
| Current Liabilities | $40.58B | |
| Total Debt | $32.04B | |
| Short Term Debt | $2.17B | |
| Accounts Payable | $6.93B |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $170.83B | |
| Operating Expenses | -$8.89B | |
| - | ||
| SG&A | $0.00 | |
| D&A | $1.39B | |
| Interest Expense | $0.00 | |
| Income Tax | $1.93B |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $5.81B | |
| CFI | -$5.17B | |
| CFF | $1.19B | |
| Capex | $1.26B | |
| Free Cash Flow | $4.55B |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Wolfe Research | → | |
| Wells Fargo | → | |
| Barclays | → | |
| Deutsche Bank | → | |
| Morgan Stanley | → | |
| TD Cowen | → | |
| Mizuho | → | |
| JP Morgan | → | |
| TD Cowen | → | |
| Wells Fargo | → |
Analyst sentiment
Institutional ownership
Screeners with ELV
FAQ
What is the ticker symbol for Elevance Health, Inc.?
The ticker symbol for Elevance Health, Inc. is NYSE:ELV
Does Elevance Health, Inc. pay dividends?
Yes, Elevance Health, Inc. pays dividends. The last payment was $1.71, with an ex-dividend date on December 5, 2025
What sector is Elevance Health, Inc. in?
Elevance Health, Inc. is in the Healthcare sector
What industry is Elevance Health, Inc. in?
Elevance Health, Inc. is in the Healthcare Plans industry
What country is Elevance Health, Inc. based in?
Elevance Health, Inc. is headquartered in United States
When did Elevance Health, Inc. go public?
Elevance Health, Inc. initial public offering (IPO) was on October 30, 2001
Is Elevance Health, Inc. in the S&P 500?
Yes, Elevance Health, Inc. is included in the S&P 500 index
Is Elevance Health, Inc. in the NASDAQ 100?
No, Elevance Health, Inc. is not included in the NASDAQ 100 index
Is Elevance Health, Inc. in the Dow Jones?
No, Elevance Health, Inc. is not included in the Dow Jones index
When was Elevance Health, Inc. last earnings report?
Elevance Health, Inc.'s most recent earnings report was on October 21, 2025
When does Elevance Health, Inc. report earnings?
The next expected earnings date for Elevance Health, Inc. is January 28, 2026
Data Sources & References
- ELV Official Website www.elevancehealth.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1156039/000115603925000136/0001156039-25-000136-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1156039/000115603925000010/0001156039-25-000010-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- ELV Profile on Yahoo Finance finance.yahoo.com/quote/ELV
- ELV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/elv